Ropivacaine 0.5% 150 MG/30 ML 30ML
Ended Awarded
- Contract number
- SPE2DB25FRXAG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,787
Award facts
- Contract value 100% obligated
- $5,786.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Ropivacaine 0.5% 150 mg/30 mL in 30 mL quantities, with a ceiling value of $5,786.97. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of May 13, 2025, and no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for the Defense Logistics Agency and military healthcare systems. As the prime contractor on the DLA Troop Support Medical IDC, the company supplies a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, and vaccines to support defense and veteran healthcare programs worldwide. The award of this ropivacaine delivery order reflects the company's ongoing capability to fulfill federal medical supply requirements through open competition and its established role within the DLA's pharmaceutical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FRXAG?
SPE2DB25FRXAG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 12, 2025.
How much is contract SPE2DB25FRXAG worth?
The government has obligated $5,787 on SPE2DB25FRXAG.
Is contract SPE2DB25FRXAG an order under another contract?
Yes. SPE2DB25FRXAG is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FRXAG competed?
The extent of competition for SPE2DB25FRXAG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award